Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Four-Arm Randomized Trial on the Effectiveness of Electroacupuncture

Table 6

Electroneurographical tests (amplitude and nerve conduction velocity) day 21–day 0 (mean ± SD).

Group	Day	Sural nerve		Median nerve
		Amplitude (norm > 10 μV)	NCV (norm > 42 m/s)	Amplitude (norm > 7 μV)	NCV (norm > 45 m/s)
EA (𝑁=13)	0	5.4±3.6	46.4±4.7	19.0±10.7	48.2±4.7
	21	7.4±6.0	46.0±3.7	16.8±7.0	48.4±4.4
Diff. mean day 21–day 0		+2.0	−0.4	−2.2	+0.2
HB (𝑁=12)	0	4.3±2.2	46.2±3.4	15.5±7.8	40.7±9.7
	21	6.3±2.6	46.8±7.1	15.9±9.8	46.3±6.3
Diff. mean day 21–day 0		+2.0	+0.6	+0.4	+5.6
VitB (𝑁=13)	0	3.9±2.7	45.0±4.3	15.9±9.8	46.9±4.1
	21	5.1±3.8	45.0±3.8	15.3±6.4	51.2±3.1
Diff. mean day 21–day 0		+1.2	±0	−0.6	+4.3
Placebo (𝑁=14)	0	5.3±3.1	45.3±4.2	17.5±9.5	47.1±7.5
	21	6.3±3.4	45.9±5.8	16.8±8.5	50.6±6.0
Diff. mean day 21–day 0		+1.0	+0.6	−0.7	+3.5